Cargando…

Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes

CONTEXT: Cardiovascular benefits of empagliflozin in patients with type 2 diabetes mellitus (T2DM) have been reported; however, the underlying mechanism remains unknown. OBJECTIVE: We hypothesized that the cardiovascular benefits of empagliflozin are associated with altered gut microbiota and plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Xinru, Zhang, Chenhong, Wang, Pengxu, Wei, Wei, Shi, Xiaoyang, Wang, Pingping, Yang, Junpeng, Wang, Limin, Tang, Shasha, Fang, Yuanyuan, Liu, Yalei, Chen, Yiqi, Zhang, Yun, Yuan, Qian, Shang, Jing, Kan, Quane, Yang, Huihui, Man, Hua, Wang, Danyu, Yuan, Huijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202724/ https://www.ncbi.nlm.nih.gov/pubmed/35397165 http://dx.doi.org/10.1210/clinem/dgac210

Ejemplares similares

Association of masked uncontrolled hypertension and cardiovascular diseases in treated hypertensive patients
por: Shi, Xiaoyang, et al.
Publicado: (2019)

Association Between Inflammatory Biomarkers and Cognitive Dysfunction Analyzed by MRI in Diabetes Patients
por: Yang, Xue, et al.
Publicado: (2020)

Vertical transmission of the gut microbiota influences glucose metabolism in offspring of mice with hyperglycaemia in pregnancy
por: Xue, Cunxi, et al.
Publicado: (2022)

Effect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients with Type 2 Diabetes Mellitus
por: Hsu, Jung-Chi, et al.
Publicado: (2019)

Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
por: Yang, Junpeng, et al.
Publicado: (2020)

Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus
por: Yang, Junpeng, et al.
Publicado: (2021)

Clinical Associations of Thyroid Hormone Levels with the Risk of Atherosclerosis in Euthyroid Type 2 Diabetic Patients in Central China
por: Wang, Limin, et al.
Publicado: (2020)

Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
por: Yang, Xueli, et al.
Publicado: (2022)

Empagliflozin: a potential anticancer drug
por: Wu, Wenwen, et al.
Publicado: (2023)

Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in mice
por: Yang, Xin, et al.
Publicado: (2023)

Lysobacter enzymogenes prevents Phytophthora infection by inhibiting pathogen growth and eliciting plant immune responses
por: Lin, Long, et al.
Publicado: (2023)

A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide
por: Liu, Tao, et al.
Publicado: (2019)

Correction to: “Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes”
Publicado: (2022)

Ketogenic Diets Induced Glucose Intolerance and Lipid Accumulation in Mice with Alterations in Gut Microbiota and Metabolites
por: Li, Yue, et al.
Publicado: (2021)

Empagliflozin for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Tang, Xue, et al.
Publicado: (2022)

Weight loss increases all-cause mortality in overweight or obese patients with diabetes: A meta-analysis
por: Chen, Yiqi, et al.
Publicado: (2018)

Empagliflozin-Pretreated Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Attenuated Heart Injury
por: Chi, Boyu, et al.
Publicado: (2023)

Comprehensive Profiling and Inheritance Patterns of Metabolites in Foxtail Millet
por: Li, Shuangdong, et al.
Publicado: (2018)

Empagliflozin in type 1 diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

Anti-inflammatory potential of Empagliflozin
por: Pirklbauer, Markus
Publicado: (2021)

Drug eruption associated with empagliflozin
por: Yau, Kevin, et al.
Publicado: (2022)

Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuyuan, et al.
Publicado: (2022)

Application of Entropy Method to Quantify Future Ecological Flow in the Yellow River Basin
por: Wang, Xinru, et al.
Publicado: (2021)

Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice
por: Zhang, Qing-Qing, et al.
Publicado: (2020)

Algae-bacteria symbiotic constructed wetlands for antibiotic wastewater purification and biological response
por: Wang, Yiqi, et al.
Publicado: (2022)

New and traditional methods for antibiotic resistance genes removal: Constructed wetland technology and photocatalysis technology
por: Chen, Pingping, et al.
Publicado: (2023)

Empagliflozin protects against renal ischemia/reperfusion injury in mice
por: Wang, Qifeng, et al.
Publicado: (2022)

Empagliflozin: Not just a glorified diuretic
por: John, Mathew
Publicado: (2016)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Empagliflozin in Patients with Chronic Kidney Disease
por: Herrington, William G., et al.
Publicado: (2023)

Masked Primary Hyperparathyroidism by Empagliflozin Use
por: Awada, Mariam, et al.
Publicado: (2022)

Role of empagliflozin in chronic lithium toxicity
por: Dyson, Vicki
Publicado: (2022)

The Use of Empagliflozin Post Myocardial Infarction
por: Ravendran, Kapilraj, et al.
Publicado: (2023)

Volatile Organic Metabolites Identify Patients with Breast Cancer, Cyclomastopathy, and Mammary Gland Fibroma
por: Wang, Changsong, et al.
Publicado: (2014)

Association analysis of gut microbiota-metabolites-neuroendocrine changes in male rats acute exposure to simulated altitude of 5500 m
por: Wang, Jianan, et al.
Publicado: (2023)

Therapeutic Efficacy of Excretory-Secretory Products of Trichinella spiralis Adult Worms on Sepsis-Induced Acute Lung Injury in a Mouse Model
por: Li, Huihui, et al.
Publicado: (2021)

Efficacy and safety of empagliflozin for type 2 diabetes mellitus: Meta-analysis of randomized controlled trials
por: Zhang, Yun-Jing, et al.
Publicado: (2018)

Analysis of Serum Metabolites to Diagnose Bicuspid Aortic Valve
por: Wang, Wenshuo, et al.
Publicado: (2016)

Stepwise Targeted Matching Strategy for Comprehensive Profiling of Xanthohumol Metabolites In Vivo and In Vitro Using UHPLC-Q-Exactive Orbitrap Mass Spectrometer
por: Yuan, Xiaoqing, et al.
Publicado: (2023)

Identification of Key Immune-Related Genes in the Treatment of Heart Failure After Myocardial Infarction with Empagliflozin Based on RNA-Seq
por: Zhang, Pei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5dttc17n6v9v8a14kklftp5smg